Work is underway planning the September edition of the Australasian Biotechnology journal, and AusBiotech members are invited to submit an article abstract for consideration. The September edition will focus on therapeutics, including medicinal cannabis, the microbiome, ageing, and regenerative medicine, as well as featuring trends in the life sciences sector and a sneak peek into the AusBiotech 2019 national conference.
Abstracts up to 150 words are welcomed by AusBiotech’s Communications Manager, Karen Parr by 19 June 2019. If your abstract is accepted, the full article will be required on or before 2 August 2019. The article length is approximately 500 words (1 page) or 1,000 words (2 pages). High resolution photos to accompany articles are also welcomed.
Australasian Biotechnology is AusBiotech’s official journal, reporting on research and business trends, commentary and news within the biotechnology and life sciences arena. With its informed and authoritative editorial, Australasian Biotechnology is a highly-effective communications vehicle for companies, universities, research institutes and centres wanting to reach out to stakeholders in the life sciences sector.
The journal is published in April and September. Articles are accepted from members based on their news value and relevance to the topics. We welcome abstracts on research, business news, and sector trends for consideration at any time of the year.
The journal is mailed on a name-and-title basis to over 3,000 AusBiotech members and investors. Its contributions are written by the sector, for the sector. Readership includes companies, government and university departments, research institutes, biotechnology and professional services providers nationally, and in key overseas markets.
The April edition can be read here.